Document is current
Any future updates will be listed below
-
Authors
Huang, Chung-Feng
Heo, Jeong
Chien, Rong-Nan
Baek, Yang-Hyun
Kao, Jia-Horng
Kim, Ju-Hyun
Chang, Ting-Tsung
Byun, Kwan-Soo
Chen, Jyh-Jou
Jeong, Sook-Hyang
Hu, Tsung-Hui
Kim, Young-Seok
Peng, Cheng-Yuan
Tak, Won-Young
Wang, Horng-Yuan
Yoon, Seung-Kew
Sheen, I.-Shyan
Youn-Jae Lee,
Hsu, Yu-Chun
Yim, Hyung-Joon
Tsai, Pei-Chien
Yeh, Ming-Lun
Ahn, Sang-Hoon
Dai, Chia-Yen
Paik, Seung-Woon
Huang, Jee-Fu
Kim, Yoon-Jun
Chuang, Wan-Long
Lim, Young-Suk
Yu, Ming-Lung https://orcid.org/0000-0001-8145-1900
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03042520 at ClinicalTrials.govDocuments that mention this clinical trial
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)
https://doi.org/10.1007/s40121-025-01145-y
-
Funding
Funding for this research was provided by:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University
- License Information
-
More Information
Article History
Received: 26 February 2025
Accepted: 21 March 2025
First Online: 10 April 2025
Declarations
:
: Ming-Lung Yu: Research support from AbbVie, Abbott, BMS, Gilead, Merck and Roche. Consultant for AbbVie, Abbott, Ascletis, BMS, Gilead Sciences, J&J, Merck, Novartis, Pharmaessential and Roche. Speaker for AbbVie, Abbott, Ascletis, BMS, Gilead Sciences, Merck, Pharmaessential and Roche. Chung-Feng Huang: Speaker for AbbVie, BMS, Gilead Sciences, Merck, and Roche. Young-Suk Lim: Research support and consultant for Gilead Sciences. Young-Seok Kim: Speaker, consultant and grant support for Gilead Sciences. Jeong Huo, Rong-Nan Chien, Yang-Hyun Baek, Jia-Horng Kao, Ju-Hyun Kim, Ting-Tsang Chang, Kwan-Soo Byun, Jyh-Jou Chen, Sook-Hyang Jeong, Tsung-Hui Hu, Cheng-Yuan Peng, Won-Young Tak, Hrong-Yuan Wang, Seung-Kew Yoon, I-Shyan Sheen, Youn-Jae Lee, Yu-Chun Hsu, Pei-Chien Tsai, Ming-Lun Yeh, Sang-Hoon Ahn, Chai-Yen Dai, Seung-Woon Paik, Jee-Fu Huang, Yoon-Jun Kim, and Wan-Long Chuang have nothing to disclose.
: The study was approved by the institutional review board of Kaohsiung Medical University Hospital (KMUHIRB-F(I)-20160082), which conforms to the guidelines of the International Conference on Harmonization for Good Clinical Practice and was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All patients provided written informed consent.
